Ideas and Opinions4 November 2014Toward Tuberculosis Elimination in Low-Incidence Countries: Reflections From a Global ConsultationKnut Lönnroth, MD, PhD, MSc, Giovanni Battista Migliori, MD, and Mario Raviglione, MDKnut Lönnroth, MD, PhD, MScFrom the World Health Organization Global Tuberculosis Programme, Geneva, Switzerland., Giovanni Battista Migliori, MDFrom the World Health Organization Global Tuberculosis Programme, Geneva, Switzerland., and Mario Raviglione, MDFrom the World Health Organization Global Tuberculosis Programme, Geneva, Switzerland.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/M14-1888 Annals Author Insight Video - Knut Lonnroth, MD, PhD, MSc; Giovanni Battista Migliori, MD; and Mario Raviglione, MD In this video, the authors offer additional insight into their Ideas and Opinions piece, "Toward Tuberculosis Elimination in Low-Incidence Countries: Reflections From a Global Consultation." SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail In July 2014, the World Health Organization (WHO) and the European Respiratory Society invited participants from 36 countries and experts in the field to a meeting in Rome, Italy, to discuss the first-ever global framework for tuberculosis elimination in low-incidence countries (1).Since Robert Koch's discovery of Mycobacterium tuberculosis in 1882, the quest for tuberculosis elimination has been high on the global public health agenda. There have been successes and setbacks, and hopes have waxed and waned. Faith in bacille Calmette–Guérin vaccination as a tool for elimination came and went. Albert Schatz and colleagues’ demonstration of the powerful effect of ...References1. World Health Organization. Towards tuberculosis elimination in low-incidence countries: a framework. Geneva: World Health Organization; 2014. Google Scholar2. Raviglione MC, Snider DE, Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA. 1995;273:220-6. [PMID: 7807661] CrossrefMedlineGoogle Scholar3. World Health Organization. Global Tuberculosis Report 2013. WHO/HTM/TB/2013.11. Geneva: World Health Organization; 2013. Google Scholar4. Raviglione M, Marais B, Floyd K, Lönnroth K, Getahun H, Migliori GB, et al. Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet. 2012;379:1902-13. [PMID: 22608339] doi:10.1016/S0140-6736(12)60727-2 CrossrefMedlineGoogle Scholar5. World Health Organization. Global strategy and targets for tuberculosis prevention, care and control after 2015. A67/11. Geneva: World Health Organization; 2014. Google Scholar6. Broekmans JF, Migliori GB, Rieder HL, Lees J, Ruutu P, Loddenkemper R, et al; World Health Organization International Union Against Tuberculosis and Lung Disease and Royal Netherlands Tuberculosis Association Working Group. European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group. Eur Respir J. 2002;19:765-75. [PMID: 11999007] MedlineGoogle Scholar7. Tuberculosis elimination revisited: obstacles, opportunities, and a renewed commitment. Advisory Council for the Elimination of Tuberculosis (ACET). MMWR Recomm Rep. 1999;48:1-13. [PMID: 10485562] MedlineGoogle Scholar8. European Centre for Disease Prevention and Control. Framework Action Plan to Fight Tuberculosis in the European Union. Stockholm, Sweden: European Centre for Disease Prevention and Control; 2008. Google Scholar9. Schwartzman K, Oxlade O, Barr RG, Grimard F, Acosta I, Baez J, et al. Domestic returns from investment in the control of tuberculosis in other countries. N Engl J Med. 2005;353:1008-20. [PMID: 16148286] CrossrefMedlineGoogle Scholar10. Lönnroth K, Castro KG, Chakaya JM, Chauhan LS, Floyd K, Glaziou P, et al. Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet. 2010;375:1814-29. [PMID: 20488524] doi:10.1016/S0140-6736(10)60483-7 CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Knut Lönnroth, MD, PhD, MSc; Giovanni Battista Migliori, MD; Mario Raviglione, MDAffiliations: From the World Health Organization Global Tuberculosis Programme, Geneva, Switzerland.Disclaimer: Drs. Lönnroth and Raviglione are staff members of the World Health Organization (WHO). They alone are responsible for the views expressed here, which do not necessarily represent the decisions or policies of the WHO.Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M14-1888.Corresponding Author: Knut Lönnroth, MD, PhD, MSc, Global Tuberculosis Programme, World Health Organization, 20 Avenue Appia, Geneva 1211, Switzerland.Current Author Addresses:Drs. Lönnroth and Raviglione: Global Tuberculosis Programme, World Health Organization, 20 Avenue Appia, Geneva 1211, Switzerland.Dr. Migliori: WHO Collaborating Centre for Tuberculosis, Salvatore Maugeri Foundation, Via Roncaccio 16, Tradate 21049, Italy.Author Contributions:Conception and design: K. Lönnroth, G.B. Migliori, M. Raviglione.Analysis and interpretation of the data: K. Lönnroth, G.B. Migliori, M. Raviglione.Drafting of the article: K. Lönnroth, G.B. Migliori, M. Raviglione.Critical revision of the article for important intellectual content: K. Lönnroth, G.B. Migliori, M. Raviglione.Final approval of the article: K. Lönnroth, G.B. Migliori, M. Raviglione.Administrative, technical, or logistic support: K. Lönnroth.Collection and assembly of data: K. Lönnroth, M. Raviglione. PreviousarticleNextarticle Advertisement Annals Author Insight Video - Knut Lonnroth, MD, PhD, MSc; Giovanni Battista Migliori, MD; and Mario Raviglione, MD In this video, the authors offer additional insight into their Ideas and Opinions piece, "Toward Tuberculosis Elimination in Low-Incidence Countries: Reflections From a Global Consultation." FiguresReferencesRelatedDetails Metrics Cited byThe Strategic Plan for Control of Tuberculosis in Australia, 2016–2020: Towards Disease EliminationBurden and Characteristics of the Comorbidity Tuberculosis—Diabetes in Europe: TBnet Prevalence Survey and Case-Control StudyClinical presentation of tuberculosis: a nine-year single-center experienceIntegrated health service delivery networks and tuberculosis avoidable hospitalizations: is there a relation between them in Brazil?WHO's new End TB StrategyTowards tuberculosis elimination: an action framework for low-incidence countriesMass prophylaxis of tuberculosis through social protection 4 November 2014Volume 161, Issue 9Page: 670-671KeywordsAttentionDrugsEpidemiologyForecastingGlobal healthHealth economicsInfectious disease epidemiologyPrevention, policy, and public healthTuberculosisVaccines ePublished: 4 November 2014 Issue Published: 4 November 2014 Copyright & PermissionsCopyright © 2014 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Lönnroth et al. (2014) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: